Application of RFA for the treatment of oligometastasis and oligo-recurrence

Research output: Contribution to journalArticlepeer-review


Radiofrequency ablation (RFA) provides favorable local efficacy in the treatment of small hepatocellular carcinoma. Thus, this modality has been applied to other types of cancer such as metastatic cancer to the liver and the lung. Herein, we focus on RFA for such metastatic cancer and introduce its clinical outcomes. Such outcomes may suggest the potential to offer long-term survival for the patients with oligo-recurrence or oligometastasis. Notable advantages of RFA include its low invasiveness, the preservation of organ function, the freedom to perform the procedure regardless of any previous therapy, and the ability to repeat the procedure whenever required.

Original languageEnglish
Pages (from-to)1069-1075
Number of pages7
JournalJapanese Journal of Clinical Radiology
Issue number8
Publication statusPublished - Aug 1 2013

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Application of RFA for the treatment of oligometastasis and oligo-recurrence'. Together they form a unique fingerprint.

Cite this